UnicoCell Biomed Co (TPE:6794) Total Current Assets: NT$787.16 Mil (As of Dec. 2025)


TPE:6794 UnicoCell Biomed Co Ltd TPE:6794
83 GF Score
Price NT$82.40
GF Value NT$101.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is UnicoCell Biomed Co Total Current Assets?

UnicoCell Biomed Co TPE:6794 83 Total Current Assets is NT$787.16 Mil as of Dec. 2025. GuruFocus rates TPE:6794 with a GF Score™ of 83/100 and a GF Value™ of NT$101.67 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. UnicoCell Biomed Co's total current assets for the quarter that ended in Dec. 2025 was NT$787.16 Mil.

UnicoCell Biomed Co  (TPE:6794) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

UnicoCell Biomed Co's Liquidation Value for the quarter that ended in Dec. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=752.02-80.577+0.75 * 2.98+0.5 * 8.404
=677.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnicoCell Biomed Co Total Current Assets Related Terms

UnicoCell Biomed Co Total Current Assets Historical Data

* Premium members only.

The historical data trend for UnicoCell Biomed Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnicoCell Biomed Co Total Current Assets Chart

UnicoCell Biomed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only 163.31 237.90 506.80 592.35 787.16

UnicoCell Biomed Co Quarterly Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 592.35 681.79 654.56 630.95 787.16
TPE:6794
83GF Score
UnicoCell Biomed Co Ltd TPE:6794
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnicoCell Biomed Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

UnicoCell Biomed Co's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=752.02+7.121+8.404+19.613
=787.16

UnicoCell Biomed Co's Total Current Assets for the quarter that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=752.02+7.121+8.404+19.613
=787.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of NT$787.16 Mil mean?
UnicoCell Biomed Co (TPE:6794) has a Total Current Assets of NT$787.16 Mil as of Dec. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for UnicoCell Biomed Co and its competitors.
Is UnicoCell Biomed Co's Total Current Assets too high?
UnicoCell Biomed Co's current Total Current Assets is NT$787.16 Mil. Overall, UnicoCell Biomed Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnicoCell Biomed Co's Total Current Assets compare to VRTX and REGN?
UnicoCell Biomed Co's Total Current Assets of NT$787.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for UnicoCell Biomed Co and its competitors. UnicoCell Biomed Co's current Total Current Assets is NT$787.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnicoCell Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, UnicoCell Biomed Co (TPE:6794) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$101.67, compared to a current price of NT$82.40 — trading 19% below its estimated fair value. The current Total Current Assets is NT$787.16 Mil. UnicoCell Biomed Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For UnicoCell Biomed Co (TPE:6794), the current Total Current Assets is NT$787.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnicoCell Biomed Co (TPE:6794) Overvalued in 2026?

Based on GuruFocus' analysis, UnicoCell Biomed Co stock appears to be undervalued. The current stock price of NT$82.40 is trading 19% below its estimated GF Value™ of NT$101.67. GuruFocus considers UnicoCell Biomed Co to be Modestly Undervalued.

Key valuation signals for TPE:6794:

  • Total Current Assets: NT$787.16 Mil
  • GF Value™: NT$101.67 vs. price of NT$82.40 (19% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the TPE:6794 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnicoCell Biomed Co Business Description

Address Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494
UnicoCell Biomed Co Ltd is engaged in new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D. It focuses on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life. The company's products include Allogeneic Adipose Stem Cell Bank, Autologous Stem Cell Therapy, Conditioned Medium, Mass Production and CDMO, Cryogenic Vial (Class 2 Medical Device), and Testing services. It operates in single segment. Geographically, its operations are spread across Taiwan, Japan and Others with Taiwan generating the majority of the revenue.
83GF Score

Get the complete analysis for TPE:6794

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$82.40
Price
NT$101.67
GF Value